Both in Pharmaceuticals
AN2 Therapeutics vs Inovio Pharmaceuticals
Over the past year ANTX returned +272.8% and INO returned −33.3%; their daily moves had a correlation of 0.02.
ANTX +272.8% INO −33.3%Growth of $1, one year, split-adjusted
| Metric | ANTX | INO |
|---|---|---|
| Price | $4.25 | $1.62 |
| Market cap | $160.4M | $167.5M |
| Today | +1.67% | −2.41% |
| 1 month | −16.2% | +43.4% |
| 6 months | −8.6% | +30.6% |
| Year to date | +272.8% | −6.9% |
| 1 year | +269.6% | −35.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $78.4M | $36.7M |
| Dividend yield | — | — |
| Volatility (60d) | 75.2% | 261.2% |
| Short % of float | 10.0% | 26.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).